BiotechTube

Bardoxolone methyl + Placebo

Phase 1Completed
1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Obese Adult Male

Conditions

Obese Adult Male

Trial Timeline

Aug 20, 2019 → Jun 18, 2020

NCT ID
NCT04018339

About Bardoxolone methyl + Placebo

Bardoxolone methyl + Placebo is a phase 1 stage product being developed by Kyowa Kirin for Obese Adult Male. The current trial status is completed. This product is registered under clinical trial identifier NCT04018339. Target conditions include Obese Adult Male.

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT04018339Phase 1Completed
NCT03550443Phase 3Terminated

Competing Products

9 competing products in Obese Adult Male

See all competitors
ProductCompanyStageHype Score
LorcaserinEisaiPhase 1
29
LIK066 + PlaceboNovartisPhase 2
35
Investigational new drug company code: BGS649 + PlaceboNovartisPhase 2
27
Placebo + CT-388RochePhase 2
39
Growth hormone treatmentPfizerPre-clinical
26
BMS-963272 + PlaceboBristol Myers SquibbPhase 1
29
ALN-4324 + PlaceboAlnylam PharmaceuticalsPhase 1/2
36
Aleniglipron + PlaceboStructure TherapeuticsPhase 2
36
CRB-913 + PlaceboCorbus PharmaceuticalsPhase 1
26